Última actualización:
April 11, 2008
Años publicados: 1990, 1995, 1997, 2005
Kniest dysplasia is one of several forms of dwarfism that is caused by a change (mutation) in a gene known as COL2A1. This gene is involved in the production of a particular protein that forms type 2 collagen, which is essential for the normal development of bones and other connective tissue. Changes in the composition of type 2 collagen lead to abnormal skeletal growth and, thus, to a variety of dwarfing conditions known as skeletal dysplasias.
Some of the signs and symptoms of Kniest dysplasia, such as short stature, enlarged knees, and cleft palate, are usually present at birth. Other characteristics may not appear for two or three years.
People with Kniest dysplasia are known to have an unusually short stature; short, deformed arms and legs; a chest that is «barrel-shaped» and abnormally short; and a relatively long trunk. Later in life, short trunk dwarfism develops due to curvature of the spine and enlargement of the joints.
People with Kniest dysplasia have an unusually flat face with protruding eyes, and a low nasal bridge. A cleft palate may also be present, and speech impairment may occur. Involvement of the eyes may include nearsightedness (myopia) that can progress to retinal detachment and cataracts. Dislocated eye lenses, drooping of the eyelids (blepharoptosis), possible blindness with disease of the optic nerve, involvement of the spine or brain, and glaucoma may also occur. As the person matures, the joints may become enlarged causing limited movement and pain. Limbs are short, often bowed, and there may be irregularities of the ends of the long bones (epiphyses). Contracted hips may cause walking difficulties and there may be a congenital flattening of the vertebrae and a hump of the spine. Affected individuals may sometimes exhibit hernias of the groin (inguinal) and navel (umbilical), frequent ear infections, slowed motor development and hearing loss.
Also characteristic of Kniest dysplasia are holes in the individual’s cartilage, creating a «Swiss-cheese» appearance in cartilage that is significant for diagnostic purposes.
One variant of Kniest dysplasia that is extremely rare is known as Kniest-like dysplasia with pursed lips and ectopia lentis or Burton disease. It is characterized by a small mouth (microstomia) and pursed lips. In this variant, the collagen does not have the holes mentioned above.
Kniest dysplasia is the result of a change (mutation) in the gene known as COL2A1, which produces (codes for) the protein that forms collagen type 2. This gene has been mapped to the following gene map locus: 12q13.11-q13.20. The disorder is transmitted from parent to child as an autosomal dominant trait. In some instances, the mutation appears to be spontaneous, occurring for no apparent reason.
Chromosomes, which are present in the nucleus of human cells, carry the genetic information for each individual. Human body cells normally have 46 chromosomes. Pairs of human chromosomes are numbered from 1 through 22 and the sex chromosomes are designated X and Y. Males have one X and one Y chromosome and females have two X chromosomes. Each chromosome has a short arm designated «p» and a long arm designated «q». Chromosomes are further sub-divided into many bands that are numbered. For example, «12q13.11-q13.20» refers to a region between bands 13.11 and 13.20 on the long arm of chromosome 12. The numbered bands specify the location of the thousands of genes that are present on each chromosome.
Genetic diseases are determined by the combination of genes for a particular trait that are on the chromosomes received from the father and the mother.
Dominant genetic disorders occur when only a single copy of an abnormal gene is necessary for the appearance of the disease. The abnormal gene can be inherited from either parent, or can be the result of a new mutation (gene change) in the affected individual. The risk of passing the abnormal gene from affected parent to offspring is 50% for each pregnancy regardless of the sex of the resulting child.
Recessive genetic disorders occur when an individual inherits the same abnormal gene for the same trait from each parent. If an individual receives one normal gene and one gene for the disease, the person will be a carrier for the disease, but usually will not show symptoms. The risk for two carrier parents to both pass the defective gene and, therefore, have an affected child is 25% with each pregnancy. The risk to have a child who is a carrier like the parents is 50% with each pregnancy. The chance for a child to receive normal genes from both parents and be genetically normal for that particular trait is 25%. The risk is the same for males and females.
All individuals carry a few abnormal genes. Parents who are close relatives (consanguineous) have a higher chance than unrelated parents to both carry the same abnormal gene, which increases the risk to have children with a recessive genetic disorder.
X-linked recessive genetic disorders are conditions caused by an abnormal gene on the X chromosome. Females have two X chromosomes but one of the X chromosomes is «turned off» and all of the genes on that chromosome are inactivated. Females who have a disease gene present on one of their X chromosomes are carriers for that disorder. Carrier females usually do not display symptoms of the disorder because it is usually the X chromosome with the abnormal gene that is «turned off». A male has one X chromosome and if he inherits an X chromosome that contains a disease gene, he will develop the disease. Males with X-linked disorders pass the disease gene to all of their daughters, who will be carriers. A male cannot pass an X-linked gene to his sons because males always pass their Y chromosome instead of their X chromosome to male offspring. Female carriers of an X-linked disorder have a 25% chance with each pregnancy to have a carrier daughter like themselves, a 25% chance to have a non-carrier daughter, a 25% chance to have a son affected with the disease, and a 25% chance to have an unaffected son.
X-linked dominant disorders are also caused by an abnormal gene on the X chromosome, but in these rare conditions, females with an abnormal gene are affected with the disease. Males with an abnormal gene are more severely affected than females, and many of these males do not survive.
Kniest Syndrome is a rare disorder that affects males and females in equal numbers.
Newborns with this disorder are clearly in distress so that x-rays may be ordered. Diagnosis may frequently be made on the basis of the radiographs developed, while a bone biopsy usually clarifies more ambiguous cases.
Treatment
Treatment of Kniest syndrome usually consists of stabilization of lax joints, surgery to prevent contractures, and repair of retinal detachments and cleft palate. Genetic counseling may be of benefit for patients and their families. Other treatment is symptomatic and supportive.
Information on current clinical trials is posted on the Internet at www.clinicaltrials.gov. All studies receiving U.S. government funding, and some supported by private industry, are posted on this government web site.
For information about clinical trials being conducted at the NIH Clinical Center in Bethesda, MD, contact the NIH Patient Recruitment Office:
Tollfree: (800) 411-1222
TTY: (866) 411-1010
Email: [email protected]
For information about clinical trials sponsored by private sources, contact:
www.centerwatch.com
TEXTBOOKS
Hicks JM. Kniest Dysplasia: A Type II Collagenopathy. In: NORD Guide to Rare Disorders. Lippincott Williams & Wilkins. Philadelphia, PA. 2003:.
Gorlin RJ, Cohen MMJr, Levin LS., eds. Syndromes of the Head and Neck. 3rd ed. Oxford University Press, London, UK; 1990:206-08.
Jones KL., ed. Smith’s Recognizable Patterns of Human Malformation. 5th ed. W. B. Saunders Co., Philadelphia, PA; 1997:360-63.
JOURNAL ARTICLES
Hall CM, Elcioglu NH. Metatropic dysplasia lethal variants. Pediatr Radiol. 2004;34:66-74.
Richards AJ, Morgan J, Bearcroft PW, et al. Vitreoretinopathy with phalangeal epiphyseal dysplasia, a type II collagenopathy resulting from a novel mutation in the C-propeptide region of the molecule. 2002;39:661-65.
Wilkin DJ, Artz AS, Lachman RS, et al. Small deletions in the typeII collagen triple helix produce Kniest dysplasia. Am J Med. Genet. 1999;85:105-12.
Weis MA, Wilkin DJ, Kim HJ, et al. Structurally abnormal type II collagen in a severe form of Kniest dysplasia caused by an exon skipping mutation. J Biol Chem. 1998;273:4761-68.
FROM THE INTERNET
McKusick VA, ed. Online Mendelian Inheritance in Man (OMIM). The Johns Hopkins University. Kniest Dysplasia. Entry Number; 156550: Last Edit Date; 8/2/1999.
McKusick VA, ed. Online Mendelian Inheritance in Man (OMIM). The Johns Hopkins University. Kniest-Like Dysplasia with Pursed Lips and Ectopia Lentis. Entry Number; 245160: Last Edit Date; 12/29/1998.
Kniest Syndrome. International Birth Defects Information Systems (IBIS). ©2003. 4pp.
https://ibis-birthdefects.org/start/kniest.htm
Type II Collagen Conditions. Greenberg Center for Skeletal Dysplasias. Updated 9/12/2002. 4pp.
www.hopkinsmedicine.org/greenbergcenter/SED.htm
Kniest Syndrome Group. Welcome to the KSG (Kniest SED Group) page for Spondyloepimetaphyseal Dysplasia (SMD) & Spondyloepiphyseal Dysplasia (SED) & Kniest. nd. 4pp.
www.ksginfo.org/main.htm
Kniest Syndrome Group. Frequently asked questions about Kniest Dysplasia. nd. 4pp.
www.ksginfo.org/kniest.html
Kniest dysplasia. Orphanet. April 2004. 2pp.
www.orpha.net/staticGB/kniest_dysplasia
NORD y la Fundación MedicAlert se han asociado en un nuevo programa para brindar protección a pacientes con enfermedades raras en situaciones de emergencia.
Aprende más https://rarediseases.org/patient-assistance-programs/medicalert-assistance-program/Asegurarse de que los pacientes y los cuidadores estén equipados con las herramientas que necesitan para vivir su mejor vida mientras manejan su condición rara es una parte vital de la misión de NORD.
Aprende más https://rarediseases.org/patient-assistance-programs/rare-disease-educational-support/Este programa de asistencia, primero en su tipo, está diseñado para los cuidadores de un niño o adulto diagnosticado con un trastorno raro.
Aprende más https://rarediseases.org/patient-assistance-programs/caregiver-respite/The information provided on this page is for informational purposes only. The National Organization for Rare Disorders (NORD) does not endorse the information presented. The content has been gathered in partnership with the MONDO Disease Ontology. Please consult with a healthcare professional for medical advice and treatment.
The Genetic and Rare Diseases Information Center (GARD) has information and resources for patients, caregivers, and families that may be helpful before and after diagnosis of this condition. GARD is a program of the National Center for Advancing Translational Sciences (NCATS), part of the National Institutes of Health (NIH).
View reportOrphanet has a summary about this condition that may include information on the diagnosis, care, and treatment as well as other resources. Some of the information and resources are available in languages other than English. The summary may include medical terms, so we encourage you to share and discuss this information with your doctor. Orphanet is the French National Institute for Health and Medical Research and the Health Programme of the European Union.
View reportOnline Mendelian Inheritance In Man (OMIM) has a summary of published research about this condition and includes references from the medical literature. The summary contains medical and scientific terms, so we encourage you to share and discuss this information with your doctor. OMIM is authored and edited at the McKusick-Nathans Institute of Genetic Medicine, Johns Hopkins University School of Medicine.
View report